Recent Advances in Targeting Inflammation

Dr. Gautam Sethi is a tenured Associate Professor in the Department of Pharmacology at the Yong Loo Lin School of Medicine, National University of Singapore. His research focuses on elucidating the molecular mechanisms underlying cancer initiation and progression, particularly the activation of oncogenic transcription factors by carcinogens and inflammatory agents, and the identification of novel therapeutic inhibitors. Dr. Sethi has made substantial and direct scholarly contributions to the fields of gut microbiota, cancer pathophysiology, and host–microbiome interactions, with particular emphasis on immunotherapy, tumor microenvironment modulation, metabolic signaling, and therapy response prediction. He has authored numerous peer-reviewed research and review articles in high-impact journals, received multiple international awards, and serves on the editorial boards of more than 15 international journals.

Dr. Ankita Chatterjee is an Assistant Professor in Department of Biotechnology, School of Applied Sciences, REVA University, Bangalore, India. Her research area includes microbial technology focusing on the effect of microorganisms and microbial metabolites in reducing the environmental pollutants. The area of research also spans around extraction of pharmaceutically active bioactive compounds from natural sources and their analyses. She has 35 publications at present which include 22 research and review papers in reputed international and national journals as well as 13 book chapters in internationally edited books under reputed publishers. She has served as reviewer for various international journals.